Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Issue 10234 (2nd May 2020)

Record Type:: Journal Article
Title:: Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Issue 10234 (2nd May 2020)
Main Title:: Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Authors:: Feldmann, Marc
Maini, Ravinder N
Woody, James N
Holgate, Stephen T
Winter, Gregory
Rowland, Matthew
Richards, Duncan
Hussell, Tracy
Abstract:
Is Part Of:: Lancet. Volume 395:Issue 10234(2020)
Journal:: Lancet
Issue:: Volume 395:Issue 10234(2020)
Issue Display:: Volume 395, Issue 10234 (2020)
Year:: 2020
Volume:: 395
Issue:: 10234
Issue Sort Value:: 2020-0395-10234-0000
Page Start:: 1407
Page End:: 1409
Publication Date:: 2020-05-02
Subjects:: Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Medicine
Electronic journals
Periodicals
610.5
Journal URLs:: http://www.thelancet.com/ ↗
http://www.sciencedirect.com/science/journal/01406736 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0140-6736(20)30858-8 ↗
Languages:: English
ISSNs:: 0140-6736
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 13430.xml